A Tailored mHealth Vaping Prevention Intervention for Adolescents with Congenital Heart Defects
针对先天性心脏病青少年的定制 mHealth 电子烟预防干预措施
基本信息
- 批准号:10739666
- 负责人:
- 金额:$ 18.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-15 至 2028-07-31
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalAcuteAdherenceAdolescentAdultAffectAgeAreaBehavior TherapyBehavioralBiological MarkersBlood PressureCardiologyCardiovascular systemCaringCharacteristicsChildhoodClinicClinicalCongenital Heart DefectsCritical Congenital Heart DefectsDataDevelopment PlansDiseaseEducational CurriculumEffectivenessElectronic cigaretteFeedbackFellowshipFocus GroupsFred Hutchinson Cancer Research CenterFutureGoalsHealthHealth Care CostsHealth StatusHealth behavior and outcomesHealthcareHigh PrevalenceHypertensionIndividualInterventionKnowledgeLongevityManaged CareMentorshipMethodologyModalityMorbidity - disease rateOhioOutcomeParentsParticipantPediatric HospitalsPediatric ResearchPersonal SatisfactionPopulationPopulations at RiskPredispositionPreventionPrevention educationPrevention programPsychologyPublic HealthRecording of previous eventsReportingResearchResearch InstituteRiskRisk FactorsScienceScientistSelf ManagementSurvivorsTNFSF15 geneTeenagersTimeTobaccoTrainingTreatment EfficacyUniversitiesVulnerable PopulationsYouthacceptability and feasibilityagedarmarterial stiffnesscardiovascular healthcardiovascular risk factorcareercareer developmentcigarette smokingcombustible cigarettedesignefficacy evaluationefficacy trialelectronic cigarette useevidence basefollow-uphandheld mobile deviceinformation gatheringintervention effectmHealthmultidisciplinaryperceived stresspilot trialpreferencepreventpreventive interventionprogramsrandomized, clinical trialsrecruitretention ratesatisfactionsocial cognitive theorysociodemographicsstatisticsstress managementstress reductiontobacco preventiontreatment armtreatment as usualusabilityvapingweb page
项目摘要
PROJECT SUMMARY/ABSTRACT: Congenital heart defects (CHD) affect over 2.4 million individuals in the
U.S and generate $6.1 billion in annual healthcare costs. Avoidance of tobacco is vital to mitigate CHD
survivors’ risk for acquired cardiovascular complications, but the youth e-cigarette (“vaping”) crisis exposes the
growing and vulnerable population of adolescents (“teens”) with CHD to potential vaping-related harms and
significantly increases risk for conventional cigarette use. Interventions to prevent vaping among teens with
CHD are critically needed, but no existing programs are sufficient for this at-risk group. Dr. Fox’s TL1
fellowship research showed that 31% of teens with CHD are susceptible to vaping and identified perceived
stress and poor disease knowledge as potential risk factors, but existing programs do not address these
considerations. The proposed research will generate and evaluate the first vaping prevention intervention
tailored for teens with CHD. Aim 1: Adapt curriculum from an evidence-based, classroom-delivered vaping
prevention intervention to include critical stress management and disease knowledge modules in a mobile
Health (mHealth) format for teens (12-18 years) with CHD. Intervention adaptation/refinement will occur via: 1)
focus groups with key stakeholders (teens with CHD, parents, cardiologists) to understand intervention
preferences, and 2) a single-arm pilot trial of the adapted mHealth intervention (N=16) with follow-up focus
groups to gather information for refinement. Aim 2: Evaluate the feasibility/acceptability of the mHealth
intervention via a pilot randomized clinical trial (RCT; N=72). Exploratory Aim 3: Explore the preliminary
efficacy of the mHealth intervention for indicators of vaping prevention (vaping-related efficacy, perceived
vaping outcomes, e-cigarette knowledge). These aims directly align with Dr. Fox’s career goal of becoming an
independent clinician-scientist with expertise in behavioral RCTs and scalable disease self-management
interventions for transition-aged teens with CHD. To achieve this goal, Dr. Fox requires advanced training in
the following areas: 1) behavioral intervention science to design and optimize interventions that can be
implemented on a public health level, such as mHealth modalities, 2) RCT methodology and analysis to
rigorously evaluate behavioral interventions for efficacy and effectiveness, and 3) CHD disease self-
management and healthcare for transition-aged teens to incorporate unique factors of living with CHD into
tailored interventions. The career development plan involves didactic and applied training and leverages expert
multidisciplinary (public health, clinical/quantitative psychology, cardiology) mentorship from The Abigail
Wexner Research Institute at Nationwide Children’s Hospital, one of the worlds’ fastest growing pediatric
research centers, its academic affiliate The Ohio State University, and the Fred Hutchinson Cancer Research
Center. This K23 proposal will provide high-quality preliminary data and instill expertise needed for an R01
efficacy trial, advancing toward the ultimate goal of enhancing wellbeing across the lifespan of CHD.
项目摘要/摘要:先天性心脏缺陷(CHD)影响超过240万人
美国并产生61亿美元的年度医疗费用。避免烟草对于减轻冠心病至关重要
幸存者发生心血管并发症的风险,但青年电子烟(“ vaping”)危机暴露了
与毒品相关的危害和
显着增加了常规香烟使用的风险。防止青少年烟的干预措施
冠心病是至关重要的,但是对于这个高危人群,现有的计划不足以足够。福克斯博士的TL1
奖学金研究表明,有31%的冠心病青少年容易受到烟的影响和识别
压力和疾病知识不足是潜在的危险因素,但现有计划并未解决这些问题
考虑因素。拟议的研究将生成和评估第一次预防干预
针对青少年量身定制的CHD。 AIM 1:调整基于循证的,教室的烟雾的课程
预防干预措施,包括移动中的关键压力管理和疾病知识模块
与CHD的青少年(12-18岁)的健康(MHealth)格式。干预适应/改进将通过以下方式进行:1)
与主要利益相关者(与冠心病的青少年,父母,心脏病学家)一起了解干预的焦点小组
偏好和2)适用于MHealth干预措施(n = 16)的单臂试点试验,随访重点
小组收集信息进行改进。目标2:评估MHealth的可行性/可接受性
通过试验随机临床试验(RCT; n = 72)进行干预。探索目的3:探索初步
MHealth干预效率对于预防烟雾的指标(与烟有关的效率,感知到
蒸发结果,电子烟知识)。这些目标直接与福克斯博士的职业目标保持一致
独立的临床科学家具有行为RCT和可扩展疾病自我管理方面的专业知识
与CHD过渡时期青少年的干预措施。为了实现这一目标,福克斯博士需要高级培训
以下领域:1)行为干预科学设计和优化可以是的干预措施
在公共卫生层面上实施,例如MHealth模式,2)RCT方法论和分析
严格评估行为干预措施的有效性和有效性,3)冠心病自我
过渡时代青少年的管理和医疗保健将冠心病生活的独特因素纳入
量身定制的干预措施。职业发展计划涉及教学和应用培训和利用专家
多学科(公共卫生,临床/定量心理学,心脏病学)Abigail的精神训练
全国儿童医院的韦克斯纳研究所,这是世界上增长最快的儿科之一
研究中心,俄亥俄州立大学的学术会员和弗雷德·哈钦森癌症研究
中心。该K23提案将提供R01所需的高质量初步数据和灌输专业知识
功效试验,朝着在整个CHD寿命中增强健康的最终目标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kristen R. Fox其他文献
Kristen R. Fox的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
用于急性出血控制的硅酸钙复合海绵的构建及其促凝血性能和机制研究
- 批准号:32301097
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
AF9通过ARRB2-MRGPRB2介导肠固有肥大细胞活化促进重症急性胰腺炎发生MOF的研究
- 批准号:82300739
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
代谢工程化MSC胞外囊泡靶向调控巨噬细胞线粒体动力学改善急性肾损伤的作用及机制研究
- 批准号:32371426
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
DUSP2介导自噬调控气管上皮细胞炎症在急性肺损伤中的机制研究
- 批准号:82360379
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
超声射频信号神经回路策略模型定量肌肉脂肪化评估慢加急性肝衰竭预后
- 批准号:82302221
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Virtual-Reality Assessment and Treatment of Binocular Vision Impairment in Traumatic Brain Injury
创伤性脑损伤双眼视觉障碍的虚拟现实评估和治疗
- 批准号:
10832455 - 财政年份:2021
- 资助金额:
$ 18.74万 - 项目类别:
Pain Rehabilitation Virtual Reality (PRVR): Innovations to enhance mobility in the presence of pain
疼痛康复虚拟现实 (PRVR):增强疼痛时活动能力的创新
- 批准号:
10397145 - 财政年份:2021
- 资助金额:
$ 18.74万 - 项目类别:
Pain Rehabilitation Virtual Reality (PRVR): Innovations to enhance mobility in the presence of pain
疼痛康复虚拟现实 (PRVR):增强疼痛时活动能力的创新
- 批准号:
10615631 - 财政年份:2021
- 资助金额:
$ 18.74万 - 项目类别:
Virtual-Reality Assessment and Treatment of Binocular Vision Impairment in Traumatic Brain Injury
创伤性脑损伤双眼视觉障碍的虚拟现实评估和治疗
- 批准号:
10259948 - 财政年份:2021
- 资助金额:
$ 18.74万 - 项目类别:
Virtual-Reality Assessment and Treatment of Binocular Vision Impairment in Traumatic Brain Injury
创伤性脑损伤双眼视觉障碍的虚拟现实评估和治疗
- 批准号:
10426240 - 财政年份:2021
- 资助金额:
$ 18.74万 - 项目类别: